These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23991898)

  • 21. Fulminant gastrointestinal bleeding caused by EBV-triggered hemophagocytic lymphohistiocytosis: report of a case.
    Klein S; Schmidt C; La Rosée P; Pletz M; Harz S; Dirsch O; Fritzenwanger M; Stallmach A
    Z Gastroenterol; 2014 Apr; 52(4):354-9. PubMed ID: 24718941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical Characteristics Analysis of EBV-associated Hemophagocytic Lymphohistiocytosis Patients with Acute Kidney Injury].
    Zhao MY; Qiu Y; Liu JF; Guo DC; Lin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1248-1257. PubMed ID: 39192427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A heart breaking case of rapidly developing severe hemophagocytic syndrome secondary to chronic active EBV infection; a case report and review of the literature.
    Tawfik K; Liron Y; Ayman AR; Schneider R; Wolf DG; Ronen L
    J Clin Virol; 2015 Jun; 67():14-6. PubMed ID: 25959150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab.
    Kato M; Lee S; Morishita T; Fujita K; Tagami A; Araki H; Sugihara JI
    J Infect Chemother; 2022 Jun; 28(6):823-827. PubMed ID: 35135708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic difficulties of the hemophagocytic lymphohistiocytosis (HLH) associated with the Epstein-Barr virus.
    Gonzalo DH; Rodriguez G; Marcilla D
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):206-7. PubMed ID: 17356405
    [No Abstract]   [Full Text] [Related]  

  • 26. Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients.
    Sonke GS; Ludwig I; van Oosten H; Baars JW; Meijer E; Kater AP; de Jong D
    Clin Infect Dis; 2008 Jul; 47(1):105-8. PubMed ID: 18491961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
    Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
    Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatopathic lymphadenitis with generalized erythroderma in a patient with epstein-barr virus-associated hemophagocytic lymphohistiocytosis.
    Lee WJ; Lee DW; Kim CH; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Am J Dermatopathol; 2010 Jun; 32(4):357-61. PubMed ID: 20010284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders.
    Chuang HC; Wang JM; Hsieh WC; Chang Y; Su IJ
    Am J Pathol; 2008 Nov; 173(5):1397-405. PubMed ID: 18832568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
    Balamuth NJ; Nichols KE; Paessler M; Teachey DT
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivation.
    Thoden J; Rieg S; Venhoff N; Wennekes V; Schmitt-Graeff A; Wagner D; Kern WV
    J Infect; 2012 Jan; 64(1):110-2. PubMed ID: 21888928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease: a mimicker of sepsis in the pediatric intensive care unit.
    Mischler M; Fleming GM; Shanley TP; Madden L; Levine J; Castle V; Filipovich AH; Cornell TT
    Pediatrics; 2007 May; 119(5):e1212-8. PubMed ID: 17403820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
    Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
    Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Use of Blood Purification in Severe Epstein-Barr Virus-Associated Hemophagocytic Syndrome.
    Huang P; Huang C; Xu H; Lu J; Tian R; Wang Z; Chen Y
    Pediatrics; 2020 Jun; 145(6):. PubMed ID: 32430444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not all cytokin storms are due to COVID-19: Hemophagotic syndrome with renal involvement secondary to extranasal lymphoma and Epstein-Barr virus. A case report during the pandemic.
    Santana Quintana A; Valga F; Vega Díaz N; Fernández JM; Quevedo Reina JC; Rincón Tirado M; Aladro Escribano S; Rodríguez Pérez JC
    Nefrologia (Engl Ed); 2021; 41(3):347-349. PubMed ID: 33069494
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia and encephalitis.
    Yamashita S; Murakami C; Izumi Y; Sawada H; Yamazaki Y; Yokota TA; Matsumoto N; Matsukura S
    Psychiatry Clin Neurosci; 1998 Aug; 52(4):449-52. PubMed ID: 9766697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus infection associated with bone marrow fibrin-ring granuloma.
    Chung HJ; Chi HS; Jang S; Park CJ
    Am J Clin Pathol; 2010 Feb; 133(2):300-4. PubMed ID: 20093240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus.
    Ueda T; Itabashi T; Yamanishi S; Tanabe Y; Migita M; Itoh Y
    J Nippon Med Sch; 2020 Jul; 87(3):166-170. PubMed ID: 32238729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kawada J; Kimura H; Shibata Y; Hara S; Hoshino Y; Kojima S; Nishikawa K; Morishima T
    J Med Virol; 2006 Mar; 78(3):400-7. PubMed ID: 16419109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.